APLP2 and pancreatic neoplasm: Our finding that APLP2 knockdown has a very disruptive influence on actin structure within pancreatic tumors in vivo (as shown in Figure 6) is particularly significant, since it has two implications for the development of novel therapies for pancreatic cancer.